In addition, functionalized nanoparticles tagged with ligands, antibodies, or peptides selectively recognize melanoma-specific markers such as glycoprotein 100 (gp100) and melanoma cell adhesion molecule (MCAM), thereby promoting drug accumulation in tumor tissue while minimizing systemic toxicity. Here, MCAM is linked to neoplasm.